QR kȏd

Crizotinib: A comprehensive review

Anaplastic lymphoma kinase (ALK) gene rearrangements are present in a small subset of non-small-cell lung cancers. ALK-positivity confers sensitivity to small-molecule ALK kinase inhibitors, such as crizotinib. The integration of crizotinib into standard treatment practice in NSCLC will rest on the...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Arvind Sahu, Kumar Prabhash, Vanita Noronha, Amit Joshi, Saral Desai
Format: Artigo
Jezik:Inglês
Izdano: Thieme Medical and Scientific Publishers Pvt. Ltd. 2013-01-01
Serija:South Asian Journal of Cancer
Teme:
Online pristup:http://journal.sajc.org/article.asp?issn=2278-330X;year=2013;volume=2;issue=2;spage=91;epage=97;aulast=Sahu
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!